Mobile App – ADA Meeting News
MOBILE APP Developed specifically for the ADA’s 85th Scientific Sessions, the coordinating mobile event app and Online Planner are your go-to meeting resources with details on educational session information, news […]
Related Articles
Mobile App – ADA Meeting News
MOBILE APP Developed specifically for the ADA’s 85th Scientific Sessions, the coordinating mobile event app and Online Planner are your go-to meeting resources with details…
Continuous Glucose Monitoring in Hospitalized Patients With Type 2 Diabetes: A Step Forward in Inpatient Glycemic Control
To determine the effect and safety of continuous glucose monitoring (CGM) use in glycemic control compared to standard approach in hospitalized patients with type 2…
Scientists Training Course 2025
EASD will hold its 31st Scientists Training Course in Barcelona, Catalonia, Spain from 10 -14 November 2025, with the objective of promoting new talents in…
Once-weekly insulin could be ‘game changer’ for adults with type 2 diabetes
CHICAGO — A once-weekly basal insulin conferred similar HbA1c to once-daily insulins among adults with type 2 diabetes, both in previous basal insulin users and…
Swapping diet drinks for water linked to greater weight loss, diabetes remission in women
CHICAGO — Women who replaced their lunchtime diet beverage with water had greater weight loss and achieved diabetes remission compared with women who continued drinking…
Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes | American Diabetes Association
A recent study found that oral semaglutide offers meaningful cardiovascular benefits for people with type 2 diabetes, lowering risk by 14%.
Intervention eliminates population weight gain, prompts patients to seek care for weight
CHICAGO — An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with population-wide weight loss, researchers reported at…
Inhaled insulin safe, effective for children with diabetes
CHICAGO — Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, according to a speaker at the…
Dr. Felicia Hill-Briggs Health Equity Trailblazers in Diabetes Award debuts – ADA Meeting News
A leading scholar in epidemiology and health equity, Tiffany L. Gary-Webb, PhD, MHS, will receive the inaugural Dr. Felicia Hill-Briggs Health Equity Trailblazers in Diabetes…
Symposium will explore next gen agents for type 2 diabetes and obesity – ADA Meeting News
Panelists, including Dimitris Papamargaritis, MCRP, PhD, will discuss emerging therapies targeting the hormones glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin.